PAR1
PAR1 (protease-activated receptor 1) is a subfamily of related G protein-coupled receptors that are activated by cleavage of part of their extracellular domain.
Products Related to PAR1(43)
- GC10140Thrombin Receptor Agonist PeptideCAS: 137339-65-2Purity: >98%
Thrombin Receptor Agonist Peptide is a synthetic thrombin receptor agonist peptide.
- GC14540SLIGKV-NH2CAS: 190383-13-2Purity: >98.00%
SLIGKV-NH2 (SLIGKV-NH2) is a highly potent protease-activated receptor-2 (PAR2) activating peptide.
- GC15817PAR-4 Agonist Peptide, amide (AY-NH2)CAS: 352017-71-1Purity: >98%
PAR-4 Agonist Peptide, amide(AY-NH2) (PAR-4-AP; AY-NH2) is a proteinase-activated receptor-4 (PAR-4) agonist, which has no effect on either PAR-1 or PAR-2 and whose effects are blocked by a PAR-4 antagonist.
- GC17514SLIGRL-NH2CAS: 171436-38-7Purity: >99.50%
SLIGRL-NH2 is a specific protease-activated receptor 2 (PAR2) agonist with an EC 50 value of approximately 10μM. SLIGRL-NH2 does not activate PAR1.
- GA23350PAR-3 (1-6) amide (human)CAS: 1872435-09-0Purity: >98%
PAR-3 (1-6) amide (human) is a proteinase-activated receptor (PAR-3) agonist peptide.
- GC10291SCH 79797 dihydrochlorideCAS: 1216720-69-2Purity: >98.00%
SCH 79797 dihydrochloride is an efficient and selective non-peptide proteinase-activated receptor 1 (PAR1) antagonist, with an IC 50 of 70nM and a Ki of 35nM.
- GC18717BMS 986120CAS: 1478712-37-6Purity: >98.00%
BMS 986120 is a compound specifically targeting protease-activated receptor 4 (PAR4), which comparably inhibited platelet aggregation (PA) induced by activation peptides selective for PAR4 (PAR4-AP) in human and monkey blood in vitro (IC 50 of 9.5±2.7 and 2.1±0.4nM, respectively).
- GC33429Protease-Activated Receptor-4CAS: 245443-52-1Purity: >98.00%
Protease-Activated Receptor-4 is the agonist of proteinase-activated receptor-4 (PAR4).
- GC33599PAR-4 Agonist Peptide, amide TFA (PAR-4-AP (TFA))CAS: 1228078-65-6Purity: >99.50%
PAR-4 agonist peptide, amide TFA (PAR-4-AP (TFA)) is a synthetic peptide primarily used to activate protease-activated receptor 4 (PAR-4) .
- GC37770TFLLR-NH2(TFA)CAS: 1313730-19-6Purity: >99.50%
TFLLR-NH2 (TFA) is a selective PAR1 agonist with an EC50 of 1.9 μM.
- GC37852UDM-001651CAS: 1477497-01-0Purity: >98%
UDM-001651 is a potent, selective, and orally bioavailable protease-activated receptor 4 (PAR4) antagonist (IC50=4 nM; Kd=1.4 nM).
- GC38134Parmodulin 2CAS: 423735-93-7Purity: >98%
Reversible inhibitor of PAR1mediated platelet activation
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10140 | Thrombin Receptor Agonist Peptide | 137339-65-2 | >98% | |
Thrombin Receptor Agonist Peptide is a synthetic thrombin receptor agonist peptide. | ||||
| GC11662 | TRAP-6 | 141136-83-6 | >99.50% | |
TRAP-6 is a selective protease-activated receptor 1 (PAR1) agonist composed of six amino acids. | ||||
| GC11727 | VKGILS-NH2 | 942413-05-0 | >99.50% | |
control peptide for SLIGKV-NH2, PAR1 agonist | ||||
| GC11951 | PAR 4 (1-6) | 225779-44-2 | >98% | |
PAR4 agonist | ||||
| GC13227 | LRGILS-NH2 | 245329-01-5 | >98% | |
Protease-activated receptor agonist | ||||
| GC14540 | SLIGKV-NH2 | 190383-13-2 | >98.00% | |
SLIGKV-NH2 (SLIGKV-NH2) is a highly potent protease-activated receptor-2 (PAR2) activating peptide. | ||||
| GC14831 | AC 264613 | 1051487-82-1 | >95.00% | |
PAR2 agonist,potent and selective | ||||
| GC15290 | AC 55541 | 916170-19-9 | >98.50% | |
PAR2 agonist,potent and selective | ||||
| GC15817 | PAR-4 Agonist Peptide, amide (AY-NH2) | 352017-71-1 | >98% | |
PAR-4 Agonist Peptide, amide(AY-NH2) (PAR-4-AP; AY-NH2) is a proteinase-activated receptor-4 (PAR-4) agonist, which has no effect on either PAR-1 or PAR-2 and whose effects are blocked by a PAR-4 antagonist. | ||||
| GC17368 | 2-Furoyl-LIGRLO-amide | 729589-58-6 | >99.50% | |
Protease-activated receptor agonist | ||||
| GC17444 | TFLLR-NH2 | 197794-83-5 | >98% | |
PAR1 selective agonist | ||||
| GC17514 | SLIGRL-NH2 | 171436-38-7 | >99.50% | |
SLIGRL-NH2 is a specific protease-activated receptor 2 (PAR2) agonist with an EC 50 value of approximately 10μM. SLIGRL-NH2 does not activate PAR1. | ||||
| GC17991 | RLLFT-NH2 | 447408-68-6 | >98% | |
Protease-activated receptor agonist | ||||
| GA23350 | PAR-3 (1-6) amide (human) | 1872435-09-0 | >98% | |
PAR-3 (1-6) amide (human) is a proteinase-activated receptor (PAR-3) agonist peptide. | ||||
| GC10291 | SCH 79797 dihydrochloride | 1216720-69-2 | >98.00% | |
SCH 79797 dihydrochloride is an efficient and selective non-peptide proteinase-activated receptor 1 (PAR1) antagonist, with an IC 50 of 70nM and a Ki of 35nM. | ||||
| GC17545 | Vorapaxar | 618385-01-6 | >98.00% | |
Vorapaxar is an orally active, selective, and competitive antagonist of the thrombin receptor protease-activated receptor (PAR-1), with a K d value of 1.27 ± 0.3nM. Its K i value increases as plasma concentration rises, reaching 39.2 nM at 100% plasma. | ||||
| GC18152 | AZ-3451 | 2100284-59-9 | >98.00% | |
AZ-3451 is a protease-activated receptor-2 (PAR2) antagonist. | ||||
| GC18717 | BMS 986120 | 1478712-37-6 | >98.00% | |
BMS 986120 is a compound specifically targeting protease-activated receptor 4 (PAR4), which comparably inhibited platelet aggregation (PA) induced by activation peptides selective for PAR4 (PAR4-AP) in human and monkey blood in vitro (IC 50 of 9.5±2.7 and 2.1±0.4nM, respectively). | ||||
| GC33429 | Protease-Activated Receptor-4 | 245443-52-1 | >98.00% | |
Protease-Activated Receptor-4 is the agonist of proteinase-activated receptor-4 (PAR4). | ||||
| GC33599 | PAR-4 Agonist Peptide, amide TFA (PAR-4-AP (TFA)) | 1228078-65-6 | >99.50% | |
PAR-4 agonist peptide, amide TFA (PAR-4-AP (TFA)) is a synthetic peptide primarily used to activate protease-activated receptor 4 (PAR-4) . | ||||
| GC36125 | GB-110 | 1252806-70-4 | >98% | |
GB-110 is a potent, orally active, and nonpeptidic protease activated receptor 2 (PAR2) agonist. | ||||
| GC37770 | TFLLR-NH2(TFA) | 1313730-19-6 | >99.50% | |
TFLLR-NH2 (TFA) is a selective PAR1 agonist with an EC50 of 1.9 μM. | ||||
| GC37852 | UDM-001651 | 1477497-01-0 | >98% | |
UDM-001651 is a potent, selective, and orally bioavailable protease-activated receptor 4 (PAR4) antagonist (IC50=4 nM; Kd=1.4 nM). | ||||
| GC38134 | Parmodulin 2 | 423735-93-7 | >98% | |
Reversible inhibitor of PAR1mediated platelet activation | ||||
